Opioids in Hemodialysis Patients
- PMID: 33896471
- PMCID: PMC8083988
- DOI: 10.1016/j.semnephrol.2021.02.003
Opioids in Hemodialysis Patients
Abstract
Chronic pain and prescription opioid use are prevalent among patients with end-stage kidney disease treated with hemodialysis. Vulnerabilities to complications from opioid use are high in this patient population, as shown in many recent, well-conducted, patient-oriented studies. Such studies have highlighted the need for a balanced approach to pain management in hemodialysis patients that includes careful assessment of the risks and benefits of opioid prescriptions in this population. In this article, we review the available literature and experience regarding opioid prescriptions among hemodialysis patients, discuss clinical implications, and outline ongoing research.
Keywords: Buprenorphine; hemodialysis; hydrocodone; methadone; morphine; opioid; oxycodone; pain.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest statement:
Authors declare no conflict of interest.
References
-
- Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Advances in chronic kidney disease 2007;14(1):82–99. - PubMed
-
- Weisbord SD, Fried LF, Arnold RM, et al. Prevalence, severity, and importance of physical and emotional symptoms in chronic hemodialysis patients. Journal of the American Society of Nephrology 2005;16(8):2487–2494. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
